Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants

被引:0
|
作者
Xiaolong Yang
Alan Pater
Shou-Ching Tang
机构
[1] Faculty of Medicine,Division of Basic Medical Sciences
[2] Memorial University of Newfoundland,undefined
[3] Newfoundland Cancer Treatment and Research Foundation,undefined
[4] Dr. H. Bliss Murphy Cancer Centre,undefined
来源
Oncogene | 1999年 / 18卷
关键词
BAG-1; promoter; mutant p53; transactivation;
D O I
暂无
中图分类号
学科分类号
摘要
BAG-1 is an anti-apoptotic protein that interacts with Bcl-2, Bcl-XL, Hsp70/Hsc70, Raf-1 and numerous hormone or growth factor receptors. Recently, BAG-1 has been found to be overexpressed in a variety of human cancer cell lines and some tumors. However, the molecular mechanism of BAG-1 upregulation is still unclear. In this study, we cloned 0.9 kb of human genomic DNA, BGEV, 5′ flanking the BAG-1 open reading frame. BGEV subcloned into a promoterless luciferase reporter vector conferred high promoter activity in various human cancer cell lines. Deletion analysis of this sequence localized the region of maximal BAG-1 promoter activity from nucleotide positions −353 to −54, upstream of the first start codon CTG. Sequence analysis of the BAG-1 promoter region showed the absence of a TATA box but identified a CCAAT box, several GC boxes, a CpG island and several transcriptional factor binding sites, which may be important in the regulation of BAG-1 transcription. Most importantly, functional characterization of the BAG-1 promoter in vivo demonstrated that gain-of-function p53 mutants derived from human tumors upregulated the transcription of BAG-1 RNA and the expression of a reporter gene from the BAG-1 promoter. These results indicated that we have isolated the functional constitutive BAG-1 promoter. Furthermore, the data suggested that overexpression of BAG-1 in some tumors may be due to upregulation of the human BAG-1 promoter by mutant p53.
引用
收藏
页码:4546 / 4553
页数:7
相关论文
共 50 条
  • [1] Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants
    Yang, XL
    Pater, A
    Tang, SC
    ONCOGENE, 1999, 18 (32) : 4546 - 4553
  • [2] Modulation of gene expression by tumor-derived p53 mutants
    Scian, MJ
    Stagliano, KER
    Ellis, MA
    Hassan, S
    Bowman, M
    Miles, MF
    Deb, SP
    Deb, S
    CANCER RESEARCH, 2004, 64 (20) : 7447 - 7454
  • [3] Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
    Haupt, Ygal
    Blandino, Giovanni
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [4] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    Loging, WT
    Reisman, D
    ONCOGENE, 1999, 18 (52) : 7608 - 7615
  • [5] Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53
    W Troy Loging
    David Reisman
    Oncogene, 1999, 18 : 7608 - 7615
  • [6] Physical interaction with human tumor-derived p53 mutants inhibits p63 activities
    Strano, S
    Fontemaggi, G
    Costanzo, A
    Rizzo, MG
    Monti, O
    Baccarini, A
    Del Sal, G
    Levrero, M
    Sacchi, A
    Oren, M
    Blandino, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) : 18817 - 18826
  • [7] CHARACTERIZATION OF THE HUMAN P53 GENE PROMOTER
    TUCK, SP
    CRAWFORD, L
    MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (05) : 2163 - 2172
  • [8] Structure-based rescue of common tumor-derived p53 mutants
    Wieczorek, AM
    Waterman, JLF
    Waterman, MJF
    Halazonetis, TD
    NATURE MEDICINE, 1996, 2 (10) : 1143 - 1146
  • [9] Tumor-derived p53 mutants induce NF-κB2 gene expression
    Scian, MJ
    Stagliano, KER
    Anderson, MAE
    Hassan, S
    Bowman, M
    Miles, MF
    Deb, SP
    Deb, S
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (22) : 10097 - 10110
  • [10] p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
    Di Como, CJ
    Gaiddon, C
    Prives, C
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (02) : 1438 - 1449